Flow Traders U.S.’s iShares Health Innovation Active ETF BMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-30,063
Closed -$763K – 819
2022
Q1
$763K Buy
+30,063
New +$757K 0.03% 430

Other funds holding BMED

Flow Traders U.S.'s BMED Position: Q2 2022 in Review

Flow Traders U.S. sold out of iShares Health Innovation Active ETF (BMED) in Q2 2022, closing a stake of 30,063 shares — an estimated $763K sold.

Flow Traders U.S. first reported a position in BMED in Q1 2022 and held it in 1 quarter. The position peaked at $763K in Q1 2022. 4 funds tracked by Wall St. Rank hold BMED as of Q2 2022.

  • Flow Traders U.S. reported no remaining iShares Health Innovation Active ETF position as of Q2 2022 after selling out during the quarter.
  • Flow Traders U.S. sold 30,063 iShares Health Innovation Active ETF shares in Q2 2022, an estimated $763K.
  • Flow Traders U.S. first reported a position in iShares Health Innovation Active ETF in Q1 2022 and held it in 1 quarter.
  • Flow Traders U.S.'s iShares Health Innovation Active ETF position peaked at $763K in Q1 2022.
  • 4 funds tracked by Wall St. Rank held iShares Health Innovation Active ETF as of Q2 2022.

Based on Flow Traders U.S.'s 13F filing for Q2 2022, filed 12 Aug 2022.